Inhibition of Cholesterol Absorption

作者: Philippe Boucher , Hans Gerhard Vogel

DOI:

关键词:

摘要: General Considerations Acyl coenzyme A:cholesterol acyltransferase (ACAT), which catalyzes the intracellular formation of cholesteryl esters, plays an important role in intestinal absorption cholesterol, foam cell within arterial wall, and VLDL production liver. Two isoforms enzyme exist, ACAT1 expressed macrophages ACAT2 intestine Cholesterol is absorbed from gut exclusively unesterified form but appears lymph esterified with various long-chain unsaturated fatty acids. The responsible ACAT, a microsomal that utilizes acyl A cholesterol as substrates. ACAT inhibitors also have potential actions beyond inhibition absorption. Inhibition hepatic could reduce esters for packaging into lipoproteins, while deposition prevent cells atherosclerotic lesions (Nissen et al. 2006; Pal 2013; Rudel Farese 2006). Nevertheless, investigations knockout mice, it known not only rate-limiting pathway On normal chow, these mice absorb efficiently wild-type if were fed cholesterol-enriched diet. (Lee 2004; Repa 2004). Under physiological conditions, alternative pathways compensate deficiency (Hussain 2005). Human ACATcDNAwas cloned human macrophage cDNA library deficient line Chinese hamster ovary cells. cDNA, labeled K1, encoded integral membrane protein 550 amino acids (Chang 1993). treatment hypercholesterolemia atherosclerosis attractive target.

参考文章(49)
G. H. Rothblat, M. Naftulin, L. Y. Arbogast, Stimulation of acyl-CoA: cholesterol acyltransferase activity by hyperlipemic serum lipoproteins. Experimental Biology and Medicine. ,vol. 155, pp. 501- 506 ,(1977) , 10.3181/00379727-155-39838
D. B. Zilversmit, A Single Blood Sample Dual Isotope Method for the Measurement of Cholesterol Absorption in Rats Experimental Biology and Medicine. ,vol. 140, pp. 862- 865 ,(1972) , 10.3181/00379727-140-36568
ACAT inhibition and the progression of coronary atherosclerosis. The New England Journal of Medicine. ,vol. 354, pp. 2616- 2617 ,(2006) , 10.1056/NEJMC061094
K Einarsson, L Benthin, S Ewerth, G Hellers, D Ståhlberg, B Angelin, Studies on acyl-coenzyme A: cholesterol acyltransferase activity in human liver microsomes. Journal of Lipid Research. ,vol. 30, pp. 739- 746 ,(1989) , 10.1016/S0022-2275(20)38333-4
Rücker W, Reimitz H, Windler E, Greeve J, Greten H, Influence of the acyl-coenzyme A:cholesterol--acyltransferase inhibitor octimibate on cholesterol transport in rat mesenteric lymph. Drug Research. ,vol. 40, pp. 1108- 1111 ,(1990)
Yasufumi Nagata, Mari Yonemoto, Yoshikazu Iwasawa, Akiko Shimizu-Nagumo, Hiromi Hattori, Yoshio Sawazaki, Toshio Kamei, N-[2-[N'-pentyl-(6,6-dimethyl-2,4-heptadiynyl)amino]ethyl]-(2-methyl-1-naphthylthio)acetamide (FY-087) : a new acyl coenzyme A:cholesterol acyltransferase (ACAT) inhibitor of diet-induced atherosclerosis formation in mice Biochemical Pharmacology. ,vol. 49, pp. 643- 651 ,(1995) , 10.1016/0006-2952(94)00510-S
G. Schmitz, R. Niemann, B. Brennhausen, R. Krause, G. Assmann, Regulation of high density lipoprotein receptors in cultured macrophages: role of acyl-CoA:cholesterol acyltransferase. The EMBO Journal. ,vol. 4, pp. 2773- 2779 ,(1985) , 10.1002/J.1460-2075.1985.TB04003.X
C.C. Chang, H.Y. Huh, K.M. Cadigan, T.Y. Chang, Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells. Journal of Biological Chemistry. ,vol. 268, pp. 20747- 20755 ,(1993) , 10.1016/S0021-9258(19)36846-2
BR Krause, M Anderson, CL Bisgaier, T Bocan, R Bousley, P DeHart, A Essenburg, K Hamelehle, R Homan, K Kieft, In vivo evidence that the lipid-regulating activity of the ACAT inhibitor CI-976 in rats is due to inhibition of both intestinal and liver ACAT. Journal of Lipid Research. ,vol. 34, pp. 279- 294 ,(1993) , 10.1016/S0022-2275(20)40755-2